ImmunoGen Inc. (NASDAQ:IMGN)’s traded shares stood at 2.44 million during the last session, with the company’s beta value hitting 1.01. At the close of trading,
In the last trading session, 3.11 million ImmunoGen Inc. (NASDAQ:IMGN) shares changed hands as the company’s beta touched 1.00. With the company’s per share price
In last trading session, ImmunoGen Inc. (NASDAQ:IMGN) saw 8.06 million shares changing hands with its beta currently measuring 1.00. Company’s recent per share price level
ImmunoGen Inc. (NASDAQ:IMGN) has a beta value of 1.00 and has seen 1.39 million shares traded in the recent trading session. The company, currently valued
ImmunoGen Inc. (NASDAQ:IMGN)’s traded shares stood at 2.54 million during the last session, with the company’s beta value hitting 1.00. At the close of trading,
In the latest trading session, 1.06 million ImmunoGen Inc. (NASDAQ:IMGN) shares changed hands as the company’s beta touched 1.00. With the company’s most recent per
In last trading session, ImmunoGen Inc. (NASDAQ:IMGN) saw 2.41 million shares changing hands with its beta currently measuring 1.00. Company’s recent per share price level
ImmunoGen Inc. (NASDAQ:IMGN) has a beta value of 1.01 and has seen 2.0 million shares traded in the last trading session. The company, currently valued
During the last session, ImmunoGen Inc. (NASDAQ:IMGN)’s traded shares were 2.93 million, with the beta value of the company hitting 1.00. At the end of